Events

It showcase the latest innovations in AI integration, novel reimbursement avenues and alternative regulatory pathways to achieve commercial viability.

This conference will bring leading industry professionals together to share knowledge, with a focus on collaboration, advancing clinical development and concentrating on clinical operations, innovation, and technology.

Liquid biopsy testing has continued to revolutionize diagnostics and personalized medicine; from the integration of AI and automation to elevate liquid biopsy capabilities, to the approval of MRD as an endpoint in Multiple Myeloma.

Servier’s recent approval of vorasidenib for Grade 2 IDH-mutant glioma has sparked renewed hope in a space that has long struggled with limited treatment options.

A dedicated forum to advancing novel radiopharmaceutical drug discovery. Delve deep into target mining, screening, discovery and selection from ROR1, uPAR, B7-H3, NECTIN-4, CAIX and more.

This year’s all-new agenda offers unprecedented detail on optimizing digital innovation, working with regulatory and legal review partners, and exploring how to establish a culture on innovation.

This symposium offers a multidisciplinary forum dedicated to navigating the forefront of operating room leadership.

The program features in-depth discussion and analysis of the latest scientific findings and practice-changing advances in GI cancer treatment.

The conference dives deep into the changing world of breast cancer treatment, focusing on the latest updates for triple-negative, inflammatory, locally advanced, and metastatic breast cancers.

As the NK community remains determined as ever to prove the advantages of NK cells, the year of the ‘bounce back’ now feels within reach.